We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
DNA methylation as an epigenetic biomarker in colorectal cancer.
- Authors
DONIZETTI SILVA, TIAGO; MARQUES VIDIGAL, VERONICA; VITOR FELIPE, ALEDSON; MIRANDA DE LIMA, JACQUELINE; ARTIGIANI NETO, RICARDO; SIDNEY SAAD, SARHAN; MANOUKIAN FORONES, NORA
- Abstract
Sporadic colorectal cancer (CRC) is a consequence of the accumulation of genetic and epigenetic alterations that result in the transformation of normal colonic epithelial cells to adenocarcinomas. Studies have indicated that a common event in the tumorigenesis of CRC is the association of global hypomethylation with discrete hypermethylation at the promoter regions of specific genes that are involved in cell cycle regulation, DNA repair, apoptosis, angiogenesis, adhesion and invasion. The present study aimed to investigate the epigenetic changes (DNA methylation) in 24 candidate genes in CRC. A total of 10 candidate hypermethylated (HM) and unmethylated (UM) genes were identified that may be useful epigenetic markers for non-invasive CRC screening. The five genes that had the highest average UM percentages in the control group were MLH1 (71.7%), DKK2 (69.6%), CDKN2A (68.4%), APC (67.5%) and hsa-mir-342 (67.4%). RUNX3 (58.9%), PCDH10 (55.5%), SFRP5 (52.1%), IGF2 (50.4%) and Hnf1b (50.0%) were the five genes with the highest average HM percentages in the test group. In summary, the present preliminary study identified the methylation profiles of normal and cancerous colonic epithelial tissues, and provided the groundwork for future large-scale methylation studies.
- Subjects
COLON cancer diagnosis; DNA methylation; BIOMARKERS; EPIGENETICS; METHYLATION; NEOPLASTIC cell transformation; CELL cycle regulation; APOPTOSIS
- Publication
Oncology Letters, 2013, Vol 6, Issue 6, p1687
- ISSN
1792-1074
- Publication type
Article
- DOI
10.3892/ol.2013.1606